Analogously to TTF1-1, Napsin A is used in pathology to diagnose lung tumors, particularly for the differentiation of non-small-cell lung cancer (NSCLC), and can be detected in up to 90% of lung adenocarcinomas. Here, NAPSA is linked to lung adenocarcinoma.